Re: Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
H
H
Wolf
M G A J
MG
Wouters
M
M
Trijbels-Smeulders
D019072:Antibiotic Prophylaxis / Q000191:economics*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000191:economics*; D011295:Prenatal Care / Q000191:economics*; D012307:Risk Factors; D013290:Streptococcal Infections / Q000191:economics*; D013292:Streptococcus agalactiae; D014623:Vaginal Diseases / Q000191:economics*